Results 1-23 of 23 (Search time: 0.108 seconds).

Issue DateTitleAuthor(s)SourcescopusWOSFulltext/Archive link
12024Tissue or liquid rebiopsy? A prospective study for simultaneous tissue and liquid NGS after first-line EGFR inhibitor resistance in lung cancerYEN-TING LIN ; CHAO-CHI HO ; Hsu, Wei-Hsun; WEI-YU LIAO ; CHING-YAO YANG ; CHONG-JEN YU ; TZU-HSIU TSAI ; CHIH-HSIN YANG ; SHANG-GIN WU ; CHIA-LIN HSU ; Hsieh, Min-Shu; Huang, Yen-Lin; Wu, Chia-Ling; JIN-YUAN SHIH Cancer medicine
22023LncRNA SLCO4A1-AS1 suppresses lung cancer progression by sequestering the TOX4-NTSR1 signaling axisChen, Yi-Ling; Liu, Yi-Nan; YEN-TING LIN ; Tsai, Meng-Feng; SHANG-GIN WU ; Chang, Tzu-Hua; CHIA-LANG HSU ; HUEY-DONG WU ; JIN-YUAN SHIH Journal of biomedical science20
32023Upfront liquid next-generation sequencing in treatment-naïve advanced non-small cell lung cancer patients: A prospective randomised study in the Taiwanese health systemCHING-YAO YANG ; JIN-YUAN SHIH ; WEI-YU LIAO ; CHAO-CHI HO ; CHIA-LIN HSU ; TZU-HSIU TSAI ; SHANG-GIN WU ; YEN-TING LIN ; Hsu, Wei-Hsun; Jain, Suyog; Olsen, Steve; CHIH-HSIN YANG ; CHONG-JEN YU ; PAN-CHYR YANG European journal of cancer (Oxford, England : 1990)00
42023Response to Letter to the Editor: "Factors Other Than Low-Dose Computed Tomography Screening Related to Stage Shift and Improved Survival of Lung Cancer"CHING-YAO YANG ; YEN-TING LIN ; Lin, Li-Ju; PAN-CHYR YANG Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer00
52023Stage Shift Improves Lung Cancer Survival: Real-World EvidenceCHING-YAO YANG ; YEN-TING LIN ; Lin, Li Ju; Chang, Ya Hsuan; Chen, Hsuan Yu; Wang, Yi Pin; JIN-YUAN SHIH ; CHONG-JEN YU ; PAN-CHYR YANG Journal of Thoracic Oncology98
62022Risk of thromboembolism in non-small-cell lung cancers patients with different oncogenic drivers, including ROS1, ALK, and EGFR mutationsWang, H-Y; SHANG-GIN WU ; YEN-TING LIN ; CHUNG-YU CHEN ; JIN-YUAN SHIH ESMO open33
72022Cone-Beam Computed Tomography-Derived Augmented Fluoroscopy Improves the Diagnostic Yield of Endobronchial Ultrasound-Guided Transbronchial Biopsy for Peripheral Pulmonary LesionsCHING-KAI LIN ; Fan, Hung-Jen; ZONG-HAN YAO ; YEN-TING LIN ; Wen, Yueh-Feng; SHANG-GIN WU ; CHAO-CHI HO Diagnostics (Basel, Switzerland)32
82022Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Inhibitors in NSCLC: Two Heads Are Better Than OneYEN-TING LIN ; JIN-YUAN SHIH Journal of Thoracic Oncology00
92021The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 studyHuang, Yen-Hsiang; Hung, Jen-Yu; Ko, How-Wen; Su, Po-Lan; Lai, Chun-Liang; Chang, Huang-Chih; Hsia, Te-Chun; Lin, Sheng-Hao; Wu, Kuan-Li; Yang, Cheng-Ta; Su, Wu-Chou; Chu, Yi-Chun; Wang, Chin-Chou; WEI-YU LIAO ; YEN-TING LIN ; Lin, Ching-Hsiung; Lin, Meng-Chih; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Lee, Mei-Hsuan; SUNG-LIANG YU ; CHAO-CHI HO ; Chang, Gee-ChenTherapeutic advances in medical oncology22
102021Resistance profiles of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced non–small-cell lung cancer: a multicenter study using targeted next-generation sequencingYEN-TING LIN ; Chiang, Chi-Lu; Hung, Jen-Yu; Lee, Mei-Hsuan; Su, Wu-Chou; Wu, Shang-Yin; Wei, Yu-Feng; Lee, Kang-Yun; Tseng, Yen-Han; Su, Jian; Chung, Hsin-Pei; Lin, Chih-Bin; Ku, Wen-Hui; Chiang, Tsai-Shin; Chiu, Chao-Hua; JIN-YUAN SHIH European Journal of Cancer2421
112020Not All EGFR Exon 20 Insertions Are Created EqualYEN-TING LIN ; JIN-YUAN SHIH JTO clinical and research reports20
122020MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) processWang, Hsin-Yi; Liu, Yi-Nan; SHANG-GIN WU ; HSU, CHIA-LANG ; Chang, Tzu-Hua; Tsai, Meng-Feng; YEN-TING LIN ; JIN-YUAN SHIH Cancer biomarkers : section A of Disease markers2520
132020An International Real-World Analysis of the Efficacy and Safety of Lorlatinib Through Early or Expanded Access Programs in Patients With Tyrosine Kinase Inhibitor–Refractory ALK-Positive or ROS1-Positive NSCLCZhu, Viola W; YEN-TING LIN ; Kim, Dong-Wan; Loong, Herbert H; Nagasaka, Misako; To, Hao; Ang, Yvonne Li-En; Ock, Chan-Young; Tchekmedyian, Nishan; Ou, Sai-Hong Ignatius; Syn, Nicholas L; Reungwetwattana, Thanyanan; CHIA-CHI LIN ; Soo, Ross AJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer4536
142020Diagnosis of mediastinal tuberculous lymphadenitis using endobronchial ultrasound-guided transbronchial needle aspiration with rinse fluid polymerase chain reactionCHING-KAI LIN ; LI-TA KENG ; Lim C.-K.; YEN-TING LIN ; SHU-YUNG LIN ; Chen L.-Y.; ZONG-HAN YAO ; YUNG-HSUAN CHEN ; CHAO-CHI HO Journal of the Formosan Medical Association89
152020Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancerYEN-TING LIN ; TZU-HSIU TSAI ; SHANG-GIN WU ; Liu Y.-N.; CHONG-JEN YU ; JIN-YUAN SHIH Lung Cancer1717
162019The Impact of Clinical Factors, ALK Fusion Variants, and BIM Polymorphism on Crizotinib-Treated Advanced EML4–ALK Rearranged Non-small Cell Lung CancerYEN-TING LIN ; Liu Y.-N.; JIN-YUAN SHIH Frontiers in Oncology108
172019Validation of immunohistochemistry for the detection of BRAF V600E-mutated lung adenocarcinomasGow C.-H.; MIN-SHU HSIEH ; YEN-TING LIN ; Liu Y.-N.; JIN-YUAN SHIH Cancers2017
182019Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutationsYEN-TING LIN ; JIN-SHING CHEN ; WEI-YU LIAO ; CHAO-CHI HO ; CHIA-LIN HSU ; Yang C.-Y.; KUAN-YU CHEN ; JIH-HSIANG LEE ; ZHONG-ZHE LIN ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; CHONG-JEN YU International Journal of Cancer4946
192018Outcome of untreated lung nodules with histological but no microbiological evidence of tuberculosisChung C.-L.; YEN-FU CHEN ; YEN-TING LIN ; JANN-YUAN WANG ; SHUENN-WEN KUO ; JIN-SHING CHEN BMC Infectious Diseases54
202017Transthoracic Ultrasound Elastography in Pulmonary Lesions and DiseasesLim C.-K.; Chung C.-L.; YEN-TING LIN ; Chang C.-H.; Lai Y.-C.; HAO-CHIEN WANG ; CHONG-JEN YU Ultrasound in Medicine and Biology1717
212017Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-sensitive Exon 19 Insertion and Exon 20 Insertion in Patients With Advanced Non–Small-cell Lung CancerYEN-TING LIN ; Liu Y.-N.; SHANG-GIN WU ; CHIH-HSIN YANG ; JIN-YUAN SHIH Clinical Lung Cancer3226
222016Anaplastic Lymphoma Kinase (ALK) Kinase Domain Mutation Following ALK Inhibitor(s) Failure in Advanced ALK Positive Non–Small-Cell Lung Cancer: Analysis and Literature ReviewYEN-TING LIN ; CHONG-JEN YU ; CHIH-HSIN YANG ; JIN-YUAN SHIH Clinical Lung Cancer2623
232014Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancerYEN-TING LIN ; YU-FEN WANG ; CHIH-HSIN YANG ; CHONG-JEN YU ; SHANG-GIN WU ; JIN-YUAN SHIH ; PAN-CHYR YANG Journal of Thoracic Oncology4938